Separator

Linchpin of Drug Development Industry

Separator
I n the ever-evolving landscape of healthcare today the significant health problems have put across a critical need for drug development, wherein clinical trials play a pivotal role. Proving essential for medical therapies and enhancing patient outcomes, as India stands at the helm making a mark in the industry, many clinical research entities are looking up to India.

Today, India represents 3.4 percent of the generics market and ranks 14th in terms of value. Also, as per Grand View Research reports where the Indian clinical trials market size was estimated at $2.1 billion in 2022 and is expected to reach $2.21 billion in 2023, the global clinical trials market size was valued is expected to expand at a CAGR of 5.8 percent rising from at $49.8 billion in 2022 to touch a significant value.

In 2019, there was a critical shift too brought about with the New Drugs and Clinical Trial Rules (CT Rules) aimed at improving regulatory transparency, streamlining approval process, and prioritizing patient safety. Well, looking at the future outlook as India might become a desirable venue for international studies with the correct funding and given its good reputation among global pharma sponsors, there are many Clinical Research Training Institutes existing rolling up today to better accommodate the clinical trial and research field leveraging better education courses/ programs for the aspiring students/ individuals. Through our current siliconindia edition ’10 Most Promising Clinical Research Training Institutes – 2023’, we have strived to list down some of the key educators/leaders in the market to help students & parents seek the best available knowledge in the space. Do read through and let us know your feedback!